Cargando…
Computer-Aided Identification of Trypanosoma brucei Uridine Diphosphate Galactose 4′-Epimerase Inhibitors: Toward the Development of Novel Therapies for African Sleeping Sickness
[Image: see text] Trypanosoma brucei, the causative agent of human African trypanosomiasis, affects tens of thousands of sub-Saharan Africans. As current therapeutics are inadequate due to toxic side effects, drug resistance, and limited effectiveness, novel therapies are urgently needed. UDP-galact...
Autores principales: | Durrant, Jacob D., Urbaniak, Michael D., Ferguson, Michael A. J., McCammon, J. Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2010
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895357/ https://www.ncbi.nlm.nih.gov/pubmed/20527952 http://dx.doi.org/10.1021/jm100456a |
Ejemplares similares
-
The Molecular Dynamics of Trypanosoma brucei UDP-Galactose 4′-Epimerase: A Drug Target for African Sleeping Sickness
por: Friedman, Aaron J, et al.
Publicado: (2012) -
A Novel Allosteric Inhibitor of the Uridine Diphosphate N-Acetylglucosamine Pyrophosphorylase from Trypanosoma
brucei
por: Urbaniak, Michael D., et al.
Publicado: (2013) -
Trypanosoma brucei UDP-galactose-4′-epimerase in ternary complex with NAD(+) and the substrate analogue UDP-4-deoxy-4-fluoro-α-d-galactose
por: Alphey, Magnus S., et al.
Publicado: (2006) -
Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors
por: Durrant, Jacob D, et al.
Publicado: (2011) -
Cell‐Free Multi‐Enzyme Synthesis and Purification of Uridine Diphosphate Galactose
por: Mahour, Reza, et al.
Publicado: (2021)